# 12. REFERENCES — Complete Bibliography

---

## 12.1 PLACEBO FOUNDATIONAL

### Key Books

1. **Benedetti F** (2014). *Placebo Effects: Understanding the mechanisms in health and disease*, 2nd ed. Oxford University Press.

2. **Kirsch I** (2010). *The Emperor's New Drugs: Exploding the Antidepressant Myth*. Basic Books.

3. **Shapiro AK, Shapiro E** (1997). *The Powerful Placebo: From Ancient Priest to Modern Physician*. Johns Hopkins.

### Landmark Papers

4. **Moseley JB et al.** (2002). A controlled trial of arthroscopic surgery for osteoarthritis of the knee. *N Engl J Med*, 347:81-88.

5. **Beecher HK** (1955). The powerful placebo. *JAMA*, 159(17):1602-1606.

---

## 12.2 OPEN-LABEL PLACEBO

6. **Kaptchuk TJ et al.** (2010). Placebos without deception: A randomized controlled trial in irritable bowel syndrome. *PLoS ONE*, 5(12):e15591.

7. **Carvalho C et al.** (2016). Open-label placebo treatment in chronic low back pain. *Pain*, 157(12):2766-2772.

8. **Hoenemeyer TW et al.** (2018). Open-label placebo treatment for cancer-related fatigue. *Scientific Reports*, 8:2784.

9. **Schaefer M et al.** (2018). Open-label placebos reduce test anxiety and improve self-management skills. *Scientific Reports*, 8:13166.

10. **Locher C et al.** (2017). Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. *Pain*, 158(12):2320-2328.

---

## 12.3 NEUROIMAGING

11. **Petrovic P et al.** (2002). Placebo and opioid analgesia— Imaging a shared neuronal network. *Science*, 295:1737-1740.

12. **Zubieta JK et al.** (2005). Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. *J Neurosci*, 25:7754-7762.

13. **Scott DJ et al.** (2008). Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. *Arch Gen Psychiatry*, 65(2):220-231.

14. **Wager TD et al.** (2004). Placebo-induced changes in fMRI in the anticipation and experience of pain. *Science*, 303:1162-1167.

---

## 12.4 NOCEBO

15. **Colloca L, Miller FG** (2011). The nocebo effect and its relevance for clinical practice. *Psychosom Med*, 73(7):598-603.

16. **Benedetti F et al.** (2007). When words are painful: Unraveling the mechanisms of the nocebo effect. *Neuroscience*, 147(2):260-271.

17. **Cannon WB** (1942). "Voodoo" death. *American Anthropologist*, 44(2):169-181.

18. **Häuser W et al.** (2012). Nocebo phenomena in medicine. *Dtsch Arztebl Int*, 109(26):459-465.

---

## 12.5 MECHANISM

19. **Finniss DG et al.** (2010). Biological, clinical, and ethical advances of placebo effects. *Lancet*, 375(9715):686-695.

20. **Enck P et al.** (2013). The placebo response in medicine: Minimize, maximize or personalize? *Nat Rev Drug Discov*, 12:191-204.

21. **Price DD et al.** (2008). A comprehensive review of the placebo effect: Recent advances and current thought. *Annu Rev Psychol*, 59:565-590.

---

## 12.6 CONDITIONING

22. **Ader R, Cohen N** (1975). Behaviorally conditioned immunosuppression. *Psychosom Med*, 37(4):333-340.

23. **Goebel MU et al.** (2002). Behavioral conditioning of immunosuppression is possible in humans. *FASEB J*, 16(14):1869-1873.

---

## 12.7 CLINICAL APPLICATIONS

24. **Kaptchuk TJ, Miller FG** (2015). Placebo effects in medicine. *N Engl J Med*, 373:8-9.

25. **Blasi ZD et al.** (2001). Influence of context effects on health outcomes: A systematic review. *Lancet*, 357:757-762.

26. **Miller FG et al.** (2009). The ethics of placebo in clinical practice. *J Behav Med*, 32(2):131-139.

---

## 12.8 BACKEND SOURCES

### Primary Texts

27. **Yoga Sutras of Patanjali** — Sutras 1.2, 2.33, 4.1 on mind control and siddhis.

28. **Yoga Vasishtha** — "Mana eva manushyanam..." and related passages.

29. **Brihadaranyaka Upanishad** — 4.4.5 on thought creating reality.

30. **Tantras** — Various texts on Sankalpa and manifestation.

### Secondary Sources

31. **Feuerstein G** (1998). *The Yoga Tradition*. Hohm Press.

32. **Woodroffe J** (1919). *The Serpent Power*. Dover.

---

## 12.9 RELATED RESEARCH

### Psychoneuroimmunology

33. **Pert CB** (1997). *Molecules of Emotion*. Scribner.

34. **Benson H** (1975). *The Relaxation Response*. Morrow.

### Mind-Body Medicine

35. **Dossey L** (1993). *Healing Words*. HarperCollins.

36. **Kabat-Zinn J** (2013). *Full Catastrophe Living*. Bantam.

---

## 12.10 REVIEW ARTICLES

37. **Wager TD, Atlas LY** (2015). The neuroscience of placebo effects: Connecting context, learning and health. *Nat Rev Neurosci*, 16(7):403-418.

38. **Colagiuri B et al.** (2015). The placebo effect: From concepts to genes. *Neuroscience*, 307:171-190.

39. **Schedlowski M et al.** (2015). Neuro-bio-behavioral mechanisms of placebo and nocebo responses. *Pharmacol Rev*, 67(3):697-730.

40. **Geers AL, Miller FG** (2014). Understanding and translating the knowledge about placebo effects. *J Psychosom Res*, 76(6):414-418.

---

**Note:** All peer-reviewed citations are verifiable through standard academic databases (PubMed, Google Scholar). Backend sources are traditional texts with established lineage.

---

**Next:** Appendices ->





